97
Participants
Start Date
June 15, 2012
Primary Completion Date
June 15, 2015
Study Completion Date
October 12, 2018
Carboplatin
carboplatin (area under the curve (AUC) 6, administered intravenously in a single day for 6 cycles every three weeks \[21 days\])
Paclitaxel
Paclitaxel (175 mg / square meter, intravenously over three hours in one day to be repeated for 6 cycles every three weeks \[21 days\])
oregovomab
oregovomab (2 mg infused intravenously jointly during the 1st, 3rd and 5th chemotherapy cycle and 12 weeks after the 5th cycle).
Northern Indiana Cancer Research Consortium, South Bend
University of Connecticut Health Center, Farmington
Quest PharmaTech Inc.
INDUSTRY